Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

New Shuttle Vectors for Real-Time Gene Expression Analysis in Multidrug-Resistant Acinetobacter Species: In Vitro and In Vivo Responses to Environmental Stressors.

Lucidi M, Visaggio D, Prencipe E, Imperi F, Rampioni G, Cincotti G, Leoni L, Visca P.

Appl Environ Microbiol. 2019 Aug 29;85(18). pii: e01334-19. doi: 10.1128/AEM.01334-19. Print 2019 Sep 15.

PMID:
31324623
2.

Structural and functional investigation of the Small Ribosomal Subunit Biogenesis GTPase A (RsgA) from Pseudomonas aeruginosa.

Rocchio S, Santorelli D, Rinaldo S, Franceschini M, Malatesta F, Imperi F, Federici L, Travaglini-Allocatelli C, Di Matteo A.

FEBS J. 2019 Jun 14. doi: 10.1111/febs.14959. [Epub ahead of print]

PMID:
31199072
3.

Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs in Pseudomonas aeruginosa.

Imperi F, Fiscarelli EV, Visaggio D, Leoni L, Visca P.

Front Cell Infect Microbiol. 2019 Mar 11;9:49. doi: 10.3389/fcimb.2019.00049. eCollection 2019.

4.

The antimetabolite 3-bromopyruvate selectively inhibits Staphylococcus aureus.

Visca P, Pisa F, Imperi F.

Int J Antimicrob Agents. 2019 Apr;53(4):449-455. doi: 10.1016/j.ijantimicag.2018.11.008. Epub 2018 Nov 23.

PMID:
30472291
5.

Pseudomonas aeruginosa LptE is crucial for LptD assembly, cell envelope integrity, antibiotic resistance and virulence.

Lo Sciuto A, Martorana AM, Fernández-Piñar R, Mancone C, Polissi A, Imperi F.

Virulence. 2018;9(1):1718-1733. doi: 10.1080/21505594.2018.1537730.

6.

Molecular Epidemiology and Virulence Profiles of Colistin-Resistant Klebsiella pneumoniae Blood Isolates From the Hospital Agency "Ospedale dei Colli," Naples, Italy.

Esposito EP, Cervoni M, Bernardo M, Crivaro V, Cuccurullo S, Imperi F, Zarrilli R.

Front Microbiol. 2018 Jul 16;9:1463. doi: 10.3389/fmicb.2018.01463. eCollection 2018.

7.

An essential transcriptional regulator: the case of Pseudomonas aeruginosa Fur.

Visca P, Imperi F.

Future Microbiol. 2018 Jun 1;13:853-856. doi: 10.2217/fmb-2018-0081. Epub 2018 Jun 7. No abstract available.

PMID:
29877110
8.

Aminoarabinosylation of Lipid A Is Critical for the Development of Colistin Resistance in Pseudomonas aeruginosa.

Lo Sciuto A, Imperi F.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e01820-17. doi: 10.1128/AAC.01820-17. Print 2018 Mar.

9.

Effect of efflux pump inhibition on Pseudomonas aeruginosa transcriptome and virulence.

Rampioni G, Pillai CR, Longo F, Bondì R, Baldelli V, Messina M, Imperi F, Visca P, Leoni L.

Sci Rep. 2017 Sep 12;7(1):11392. doi: 10.1038/s41598-017-11892-9.

10.

Ferric Uptake Regulator Fur Is Conditionally Essential in Pseudomonas aeruginosa.

Pasqua M, Visaggio D, Lo Sciuto A, Genah S, Banin E, Visca P, Imperi F.

J Bacteriol. 2017 Oct 17;199(22). pii: e00472-17. doi: 10.1128/JB.00472-17. Print 2017 Nov 15.

11.

Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.

Costabile G, d'Angelo I, d'Emmanuele di Villa Bianca R, Mitidieri E, Pompili B, Del Porto P, Leoni L, Visca P, Miro A, Quaglia F, Imperi F, Sorrentino R, Ungaro F.

J Control Release. 2016 Sep 28;238:80-91. doi: 10.1016/j.jconrel.2016.07.029. Epub 2016 Jul 19.

PMID:
27449745
12.

Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection.

Minandri F, Imperi F, Frangipani E, Bonchi C, Visaggio D, Facchini M, Pasquali P, Bragonzi A, Visca P.

Infect Immun. 2016 Jul 21;84(8):2324-2335. doi: 10.1128/IAI.00098-16. Print 2016 Aug.

13.

In vitro and in vivo screening for novel essential cell-envelope proteins in Pseudomonas aeruginosa.

Fernández-Piñar R, Lo Sciuto A, Rossi A, Ranucci S, Bragonzi A, Imperi F.

Sci Rep. 2015 Dec 1;5:17593. doi: 10.1038/srep17593.

14.

Cell aggregation promotes pyoverdine-dependent iron uptake and virulence in Pseudomonas aeruginosa.

Visaggio D, Pasqua M, Bonchi C, Kaever V, Visca P, Imperi F.

Front Microbiol. 2015 Aug 28;6:902. doi: 10.3389/fmicb.2015.00902. eCollection 2015.

15.

Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serum.

Bonchi C, Frangipani E, Imperi F, Visca P.

Antimicrob Agents Chemother. 2015 Sep;59(9):5641-6. doi: 10.1128/AAC.01097-15. Epub 2015 Jul 6.

16.

Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology.

Costabile G, d'Angelo I, Rampioni G, Bondì R, Pompili B, Ascenzioni F, Mitidieri E, d'Emmanuele di Villa Bianca R, Sorrentino R, Miro A, Quaglia F, Imperi F, Leoni L, Ungaro F.

Mol Pharm. 2015 Aug 3;12(8):2604-17. doi: 10.1021/acs.molpharmaceut.5b00098. Epub 2015 May 27.

PMID:
25974285
17.

The periplasmic protein TolB as a potential drug target in Pseudomonas aeruginosa.

Lo Sciuto A, Fernández-Piñar R, Bertuccini L, Iosi F, Superti F, Imperi F.

PLoS One. 2014 Aug 5;9(8):e103784. doi: 10.1371/journal.pone.0103784. eCollection 2014.

18.

Pyochelin potentiates the inhibitory activity of gallium on Pseudomonas aeruginosa.

Frangipani E, Bonchi C, Minandri F, Imperi F, Visca P.

Antimicrob Agents Chemother. 2014 Sep;58(9):5572-5. doi: 10.1128/AAC.03154-14. Epub 2014 Jun 23.

19.

Cell-surface signaling in Pseudomonas: stress responses, iron transport, and pathogenicity.

Llamas MA, Imperi F, Visca P, Lamont IL.

FEMS Microbiol Rev. 2014 Jul;38(4):569-97. doi: 10.1111/1574-6976.12078. Epub 2014 Jul 2. Review.

20.

Antivirulence activity of azithromycin in Pseudomonas aeruginosa.

Imperi F, Leoni L, Visca P.

Front Microbiol. 2014 Apr 22;5:178. doi: 10.3389/fmicb.2014.00178. eCollection 2014. Review.

21.

Promises and failures of gallium as an antibacterial agent.

Minandri F, Bonchi C, Frangipani E, Imperi F, Visca P.

Future Microbiol. 2014;9(3):379-97. doi: 10.2217/fmb.14.3. Review.

PMID:
24762310
22.

Repurposing of gallium-based drugs for antibacterial therapy.

Bonchi C, Imperi F, Minandri F, Visca P, Frangipani E.

Biofactors. 2014 May-Jun;40(3):303-12. doi: 10.1002/biof.1159. Epub 2014 Feb 14. Review.

PMID:
24532037
23.

Subcellular localization of the pyoverdine biogenesis machinery of Pseudomonas aeruginosa: a membrane-associated "siderosome".

Imperi F, Visca P.

FEBS Lett. 2013 Nov 1;587(21):3387-91. doi: 10.1016/j.febslet.2013.08.039. Epub 2013 Sep 13.

24.

A new transcriptional repressor of the pseudomonas aeruginosa quorum sensing receptor gene lasR.

Longo F, Rampioni G, Bondì R, Imperi F, Fimia GM, Visca P, Zennaro E, Leoni L.

PLoS One. 2013 Jul 5;8(7):e69554. doi: 10.1371/journal.pone.0069554. Print 2013.

25.

The Gac/Rsm and cyclic-di-GMP signalling networks coordinately regulate iron uptake in Pseudomonas aeruginosa.

Frangipani E, Visaggio D, Heeb S, Kaever V, Cámara M, Visca P, Imperi F.

Environ Microbiol. 2014 Mar;16(3):676-88. doi: 10.1111/1462-2920.12164. Epub 2013 Jun 25.

PMID:
23796404
26.

The dual personality of iron chelators: growth inhibitors or promoters?

Visca P, Bonchi C, Minandri F, Frangipani E, Imperi F.

Antimicrob Agents Chemother. 2013 May;57(5):2432-3. doi: 10.1128/AAC.02529-12. No abstract available.

27.

Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity.

Imperi F, Massai F, Facchini M, Frangipani E, Visaggio D, Leoni L, Bragonzi A, Visca P.

Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7458-63. doi: 10.1073/pnas.1222706110. Epub 2013 Apr 8. Erratum in: Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16693.

28.

New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing.

Imperi F, Massai F, Ramachandran Pillai C, Longo F, Zennaro E, Rampioni G, Visca P, Leoni L.

Antimicrob Agents Chemother. 2013 Feb;57(2):996-1005. doi: 10.1128/AAC.01952-12. Epub 2012 Dec 17.

29.

In vitro and in vivo antimicrobial activities of gallium nitrate against multidrug-resistant Acinetobacter baumannii.

Antunes LC, Imperi F, Minandri F, Visca P.

Antimicrob Agents Chemother. 2012 Nov;56(11):5961-70. doi: 10.1128/AAC.01519-12. Epub 2012 Sep 10.

30.

The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity.

Imperi F, Antunes LC, Blom J, Villa L, Iacono M, Visca P, Carattoli A.

IUBMB Life. 2011 Dec;63(12):1068-74. doi: 10.1002/iub.531. Epub 2011 Oct 27. Review.

31.

Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity.

Antunes LC, Imperi F, Carattoli A, Visca P.

PLoS One. 2011;6(8):e22674. doi: 10.1371/journal.pone.0022674. Epub 2011 Aug 1.

32.

Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soap dispenser.

Lanini S, D'Arezzo S, Puro V, Martini L, Imperi F, Piselli P, Montanaro M, Paoletti S, Visca P, Ippolito G.

PLoS One. 2011 Feb 16;6(2):e17064. doi: 10.1371/journal.pone.0017064.

33.

A multitask biosensor for micro-volumetric detection of N-3-oxo-dodecanoyl-homoserine lactone quorum sensing signal.

Massai F, Imperi F, Quattrucci S, Zennaro E, Visca P, Leoni L.

Biosens Bioelectron. 2011 Apr 15;26(8):3444-9. doi: 10.1016/j.bios.2011.01.022. Epub 2011 Jan 25.

PMID:
21324665
34.

Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing scheme.

Pourcel C, Minandri F, Hauck Y, D'Arezzo S, Imperi F, Vergnaud G, Visca P.

J Clin Microbiol. 2011 Feb;49(2):539-48. doi: 10.1128/JCM.02003-10. Epub 2010 Dec 8.

35.

Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates.

Antunes LC, Imperi F, Towner KJ, Visca P.

Res Microbiol. 2011 Apr;162(3):279-84. doi: 10.1016/j.resmic.2010.10.010. Epub 2010 Dec 7.

PMID:
21144895
36.

Transcriptional control of the pvdS iron starvation sigma factor gene by the master regulator of sulfur metabolism CysB in Pseudomonas aeruginosa.

Imperi F, Tiburzi F, Fimia GM, Visca P.

Environ Microbiol. 2010 Jun;12(6):1630-42. doi: 10.1111/j.1462-2920.2010.02210.x. Epub 2010 Apr 5.

PMID:
20370820
37.

Molecular basis of pyoverdine siderophore recycling in Pseudomonas aeruginosa.

Imperi F, Tiburzi F, Visca P.

Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20440-5. doi: 10.1073/pnas.0908760106. Epub 2009 Nov 11.

38.

Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogen.

Imperi F, Ciccosanti F, Perdomo AB, Tiburzi F, Mancone C, Alonzi T, Ascenzi P, Piacentini M, Visca P, Fimia GM.

Proteomics. 2009 Apr;9(7):1901-15. doi: 10.1002/pmic.200800618.

PMID:
19333994
39.

Membrane-association determinants of the omega-amino acid monooxygenase PvdA, a pyoverdine biosynthetic enzyme from Pseudomonas aeruginosa.

Imperi F, Putignani L, Tiburzi F, Ambrosi C, Cipollone R, Ascenzi P, Visca P.

Microbiology. 2008 Sep;154(Pt 9):2804-13. doi: 10.1099/mic.0.2008/018804-0.

PMID:
18757814
40.

Is the host heme incorporated in microbial heme-proteins?

Tiburzi F, Imperi F, Visca P.

IUBMB Life. 2009 Jan;61(1):80-3. doi: 10.1002/iub.123. No abstract available.

41.

Enzymatic detoxification of cyanide: clues from Pseudomonas aeruginosa Rhodanese.

Cipollone R, Ascenzi P, Tomao P, Imperi F, Visca P.

J Mol Microbiol Biotechnol. 2008;15(2-3):199-211. doi: 10.1159/000121331. Epub 2008 Jul 28. Review.

PMID:
18685272
42.

Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group.

Iacono M, Villa L, Fortini D, Bordoni R, Imperi F, Bonnal RJ, Sicheritz-Ponten T, De Bellis G, Visca P, Cassone A, Carattoli A.

Antimicrob Agents Chemother. 2008 Jul;52(7):2616-25. doi: 10.1128/AAC.01643-07. Epub 2008 Apr 14.

43.

Abacavir and warfarin modulate allosterically kinetics of NO dissociation from ferrous nitrosylated human serum heme-albumin.

Ascenzi P, Imperi F, Coletta M, Fasano M.

Biochem Biophys Res Commun. 2008 May 2;369(2):686-91. doi: 10.1016/j.bbrc.2008.02.077. Epub 2008 Feb 26.

PMID:
18307975
44.

Intracellular levels and activity of PvdS, the major iron starvation sigma factor of Pseudomonas aeruginosa.

Tiburzi F, Imperi F, Visca P.

Mol Microbiol. 2008 Jan;67(1):213-27. Epub 2007 Nov 27.

45.

The bacterial aetiology of rosy discoloration of ancient wall paintings.

Imperi F, Caneva G, Cancellieri L, Ricci MA, Sodo A, Visca P.

Environ Microbiol. 2007 Nov;9(11):2894-902.

PMID:
17922771
46.

Do nonribosomal peptide synthetases occur in higher eukaryotes?

Tiburzi F, Visca P, Imperi F.

IUBMB Life. 2007 Nov;59(11):730-3.

47.

Microbial community structure and dynamics of dark fire-cured tobacco fermentation.

Di Giacomo M, Paolino M, Silvestro D, Vigliotta G, Imperi F, Visca P, Alifano P, Parente D.

Appl Environ Microbiol. 2007 Feb;73(3):825-37. Epub 2006 Dec 1.

48.

Pyoverdine siderophores: from biogenesis to biosignificance.

Visca P, Imperi F, Lamont IL.

Trends Microbiol. 2007 Jan;15(1):22-30. Epub 2006 Nov 21. Review.

PMID:
17118662
49.

Involvement of Pseudomonas aeruginosa rhodanese in protection from cyanide toxicity.

Cipollone R, Frangipani E, Tiburzi F, Imperi F, Ascenzi P, Visca P.

Appl Environ Microbiol. 2007 Jan;73(2):390-8. Epub 2006 Nov 10.

50.

Involvement of AlgQ in transcriptional regulation of pyoverdine genes in Pseudomonas aeruginosa PAO1.

Ambrosi C, Tiburzi F, Imperi F, Putignani L, Visca P.

J Bacteriol. 2005 Aug;187(15):5097-107.

Supplemental Content

Loading ...
Support Center